537 related articles for article (PubMed ID: 20512042)
1. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Dienel A; Schläfke S
Int Clin Psychopharmacol; 2010 Sep; 25(5):277-87. PubMed ID: 20512042
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.
Kasper S; Anghelescu I; Dienel A
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1960-7. PubMed ID: 26293583
[TBL] [Abstract][Full Text] [Related]
3. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
Woelk H; Schläfke S
Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
[TBL] [Abstract][Full Text] [Related]
4. An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.
Kasper S
Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():15-22. PubMed ID: 23808618
[TBL] [Abstract][Full Text] [Related]
5. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A
Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909
[TBL] [Abstract][Full Text] [Related]
6. Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set.
Kasper S; Möller HJ; Volz HP; Schläfke S; Dienel A
Int Clin Psychopharmacol; 2017 Jul; 32(4):195-204. PubMed ID: 28379882
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect.
Seifritz E; Schläfke S; Holsboer-Trachsler E
J Psychiatr Res; 2019 Aug; 115():69-74. PubMed ID: 31121394
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.
Möller HJ; Volz HP; Dienel A; Schläfke S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):183-193. PubMed ID: 29150713
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial.
Kasper S; Volz HP; Dienel A; Schläfke S
Eur Neuropsychopharmacol; 2016 Feb; 26(2):331-340. PubMed ID: 26718792
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Dienel A; Schläfke S
Wien Med Wochenschr; 2010 Dec; 160(21-22):547-56. PubMed ID: 21170695
[TBL] [Abstract][Full Text] [Related]
11. Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.
Dold M; Möller HJ; Volz HP; Seifritz E; Schläfke S; Bartova L; Kasper S
Eur Psychiatry; 2024 Mar; 67(1):e23. PubMed ID: 38425206
[TBL] [Abstract][Full Text] [Related]
12. Silexan in anxiety disorders: Clinical data and pharmacological background.
Kasper S; Müller WE; Volz HP; Möller HJ; Koch E; Dienel A
World J Biol Psychiatry; 2018 Sep; 19(6):412-420. PubMed ID: 28511598
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
Dold M; Bartova L; Volz HP; Seifritz E; Möller HJ; Schläfke S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1615-1628. PubMed ID: 36717399
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis.
Yap WS; Dolzhenko AV; Jalal Z; Hadi MA; Khan TM
Sci Rep; 2019 Dec; 9(1):18042. PubMed ID: 31792285
[TBL] [Abstract][Full Text] [Related]
15. No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial.
Seifritz E; Möller HJ; Volz HP; Müller WE; Hopyan T; Wacker A; Schläfke S; Kasper S
Int J Neuropsychopharmacol; 2021 Mar; 24(3):171-180. PubMed ID: 33300578
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender.
Müller WE; Sillani G; Schuwald A; Friedland K
Neurochem Int; 2021 Feb; 143():104899. PubMed ID: 33181239
[TBL] [Abstract][Full Text] [Related]
17. Silexan does not cause withdrawal symptoms even when abruptly discontinued.
Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A; Kasper S
Int J Psychiatry Clin Pract; 2017 Sep; 21(3):177-180. PubMed ID: 28319423
[TBL] [Abstract][Full Text] [Related]
18. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.
Baldinger P; Höflich AS; Mitterhauser M; Hahn A; Rami-Mark C; Spies M; Wadsak W; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522403
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder.
Uehleke B; Schaper S; Dienel A; Schlaefke S; Stange R
Phytomedicine; 2012 Jun; 19(8-9):665-71. PubMed ID: 22475718
[TBL] [Abstract][Full Text] [Related]
20. Lavender Oil Preparation (Silexan) for Treating Anxiety: An Updated Meta-Analysis.
Generoso MB; Soares A; Taiar IT; Cordeiro Q; Shiozawa P
J Clin Psychopharmacol; 2017 Feb; 37(1):115-117. PubMed ID: 27861196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
